BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36709715)

  • 21. Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma.
    Park J; Chung C
    Brain Tumor Res Treat; 2023 Apr; 11(2):86-93. PubMed ID: 37151150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
    Wang SS; Davenport AJ; Iliopoulos M; Hughes-Parry HE; Watson KA; Arcucci V; Mulazzani M; Eisenstat DD; Hansford JR; Cross RS; Jenkins MR
    Neurooncol Adv; 2023; 5(1):vdad024. PubMed ID: 37152812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A homogeneous treatment for non-DIPG diffuse midline glioma.
    Schiavello E; Biassoni V; Gattuso G; Podda M; Chiaravalli S; Barretta F; Antonelli M; De Cecco L; Pecori E; Gandola L; Massimino M
    Tumori; 2023 Jun; 109(3):269-275. PubMed ID: 35708347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.
    Valvi S; Manoharan N; Mateos MK; Hassall TE; Ziegler DS; McCowage GB; Dun MD; Eisenstat DD; Gottardo NG; Hansford JR
    Med J Aust; 2024 Jun; 220(10):533-538. PubMed ID: 38699949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric diffuse intrinsic pontine glioma: where do we stand?
    Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
    Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
    Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse intrinsic pontine gliomas: treatments and controversies.
    Bredlau AL; Korones DN
    Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic Resonance Imaging-Guided Focused Ultrasound-Based Delivery of Radiolabeled Copper Nanoclusters to Diffuse Intrinsic Pontine Glioma.
    Zhang X; Ye D; Yang L; Yue Y; Sultan D; Pacia CP; Pang H; Detering L; Heo GS; Luehmann H; Choksi A; Sethi A; Limbrick DD; Becher OJ; Tai YC; Rubin JB; Chen H; Liu Y
    ACS Appl Nano Mater; 2020 Nov; 3(11):11129-11134. PubMed ID: 34337344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas.
    Noon A; Galban S
    Neoplasia; 2023 Jun; 40():100899. PubMed ID: 37030112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.
    Persson ML; Douglas AM; Alvaro F; Faridi P; Larsen MR; Alonso MM; Vitanza NA; Dun MD
    Neuro Oncol; 2022 Sep; 24(9):1408-1422. PubMed ID: 35481923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
    Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
    Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of focused ultrasound for pediatric brain tumors: current insights and future implications on treatment strategies.
    Chesney KM; Keating GF; Patel N; Kilburn L; Fonseca A; Wu CC; Nazarian J; Packer RJ; Donoho DA; Oluigbo C; Myseros JS; Keating RF; Syed HR
    Childs Nerv Syst; 2024 May; ():. PubMed ID: 38702518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
    Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
    J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
    Hashizume R
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
    Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
    Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
    Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
    Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
    [No Abstract]   [Full Text] [Related]  

  • 37. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
    J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.
    Rechberger JS; Power BT; Power EA; Nesvick CL; Daniels DJ
    Expert Opin Ther Targets; 2023 Jan; 27(1):9-17. PubMed ID: 36744399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
    Deweyert A; Iredale E; Xu H; Wong E; Schmid S; Hebb MO
    J Neurooncol; 2019 May; 143(1):49-56. PubMed ID: 30852713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.